Question

Difficulty: MediumBreast and Endocrine Surgery

A 45-year-old woman is referred to the surgery clinic for evaluation of an enlarging anterior neck mass. Over the past 6 months, she has noticed a lump in her lower neck. During this time, she has also experienced worsening fatigue, constipation, cold intolerance, and a 4.5-kg (10-lb) weight gain. She has not had any difficulty swallowing or breathing. Her menstrual periods ceased one year ago. Physical examination reveals a non-tender, 3.5-cm, firm, mobile nodule in the right lobe of the thyroid gland. No cervical lymphadenopathy is present.

Laboratory studies show:

TestResultReference Range
Thyroid-stimulating hormone (TSH)0.2 \muU/mL0.2 \text{ \mu U/mL}0.5−5.0 \muU/mL0.5 - 5.0 \text{ \mu U/mL}
Free T40.4 ng/dL0.4 \text{ ng/dL}0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL}

Which of the following is the most appropriate next step in the management of this patient?

  1. Measurement of morning serum cortisolAnswer
  2. B
    Initiation of levothyroxine therapy
  3. C
    Radionuclide thyroid scintigraphy
  4. D
    Fine-needle aspiration of the thyroid nodule
  5. E
    Measurement of thyroid-stimulating immunoglobulins

Answer

Measurement of morning serum cortisol is the most appropriate next step to safely evaluate for central adrenal insufficiency prior to any further intervention.
The patient's laboratory results demonstrate a low TSH and a low Free T4, which is the hallmark of central (secondary) hypothyroidism. This diagnosis is further supported by her systemic symptoms (fatigue, weight gain) and amenorrhea, strongly pointing toward broader hypopituitarism (such as from a pituitary macroadenoma). The 3.5-cm thyroid nodule is likely an incidental finding or an unrelated benign process. When central hypothyroidism is diagnosed, it is an absolute mandate to evaluate the patient for concurrent central adrenal insufficiency before initiating levothyroxine or performing any invasive procedures (including surgery or biopsy). Thyroid hormone replacement increases the hepatic metabolism and clearance of cortisol; therefore, administering levothyroxine to a patient with unrecognized adrenal insufficiency can precipitate a fatal adrenal crisis. Similarly, the physiological stress of an invasive surgical procedure requires an intact adrenal response. Assessing morning serum cortisol is the critical next step to ensure patient safety.

Step-by-Step Solution

1
Interpret the thyroid function tests.
Both TSH and Free T4 are below normal reference ranges.
To distinguish the etiology of thyroid dysfunction. A low Free T4 with an inappropriately low or normal TSH confirms central (secondary) hypothyroidism, rather than a primary thyroid disorder.
2
Correlate laboratory findings with the clinical presentation.
The patient has central hypothyroidism alongside amenorrhea.
This combination strongly points toward broader hypopituitarism (e.g., a pituitary adenoma) rather than an isolated thyroid issue, making the thyroid nodule likely an incidental finding.
3
Determine the safest sequence of management.
Select morning serum cortisol testing.
In panhypopituitarism, central adrenal insufficiency is often present. Administering levothyroxine (which increases cortisol clearance) or subjecting the patient to the stress of an invasive procedure (like an FNA or surgery) without adequate cortisol reserve can precipitate a life-threatening adrenal crisis.

Key Concept

In patients presenting with central hypothyroidism (low TSH, low T4), the adrenal axis must be evaluated with a serum cortisol level to rule out concurrent central adrenal insufficiency before initiating levothyroxine therapy or performing invasive procedures.
Rate this question